Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 2
1993 2
1995 1
1998 1
1999 2
2001 2
2004 1
2005 1
2006 2
2007 4
2008 5
2009 2
2011 2
2012 3
2013 1
2014 2
2015 3
2016 4
2017 2
2018 3
2019 2
2020 2
2021 1
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Primary Peritoneal Carcinoma"
Page 1
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto.
Hashimoto D, Satoi S, Fujii T, Sho M, He J, Hackert T, Del Chiaro M, Jang JY, Gulla A, Yoon YS, Shan YS, Lou W, Valente R, Furuse J, Oba A, Nagai M, Terai T, Tanaka H, Sakai A, Yamamoto T, Yamaki S, Matsumoto I, Murakami Y, Takaori K, Takeyama Y. Hashimoto D, et al. Pancreatology. 2023 Sep;23(6):682-688. doi: 10.1016/j.pan.2023.07.005. Epub 2023 Jul 20. Pancreatology. 2023. PMID: 37507301 Review.
Pancreatic ductal adenocarcinoma (PDAC) is a typical refractory malignancy, and many patients have distant organ metastases at diagnosis, such as liver metastasis and peritoneal dissemination. The standard treatment for unresectable PDAC with distant organ metastasi …
Pancreatic ductal adenocarcinoma (PDAC) is a typical refractory malignancy, and many patients have distant organ metastases at diagnosis, su …
Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches.
Guro H, Kim JW, Choi Y, Cho JY, Yoon YS, Han HS. Guro H, et al. Surg Oncol. 2017 Jun;26(2):146-152. doi: 10.1016/j.suronc.2017.03.001. Epub 2017 Mar 7. Surg Oncol. 2017. PMID: 28577720 Review.
Intrahepatic cholangiocarcinoma (ICC) is a common primary hepatic tumor. However, its outcomes are usually worse than those of hepatocellular carcinoma owing to its non-specific presentation and detection at an advanced stage. ...Although lymph node metastasis is a …
Intrahepatic cholangiocarcinoma (ICC) is a common primary hepatic tumor. However, its outcomes are usually worse than those of hepato …
Conversion Surgery After Atezolizumab Plus Bevacizumab for Primary and Peritoneal Metastasis After Hepatocellular Carcinoma Rupture.
Miyata T, Sugi K, Horino T, Ono A, Tagayasu Y, Nomoto D, Inoue M, Mizumoto T, Kubota T, Yanagida E, Murayama T, Miyanari N, Baba H. Miyata T, et al. Anticancer Res. 2023 Feb;43(2):943-947. doi: 10.21873/anticanres.16239. Anticancer Res. 2023. PMID: 36697062
BACKGROUND/AIM: Conversion surgery (CS) following atezolizumab plus bevacizumab (Atez+Bev) is a treatment strategy for unresectable hepatocellular carcinoma (UR-HCC). Herein, we report a case of CS after transcatheter arterial embolization (TAE) and Atez+Bev for …
BACKGROUND/AIM: Conversion surgery (CS) following atezolizumab plus bevacizumab (Atez+Bev) is a treatment strategy for unresectable h …
Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.
Ajani JA, Mansfield PF, Ota DM. Ajani JA, et al. World J Surg. 1995 Mar-Apr;19(2):216-20. doi: 10.1007/BF00308629. World J Surg. 1995. PMID: 7754626 Review.
Unresectable gastric carcinoma is an incurable disease with the exception of a small fraction of patients who are salvaged with chemoradiotherapy. ...To date, several studies using preoperative chemotherapy have demonstrated its feasibility. The effectiveness of rep …
Unresectable gastric carcinoma is an incurable disease with the exception of a small fraction of patients who are salvaged wit …
Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
Li X, Ying H, Cheng Y, Zhao L, Zhao S, Bai C, Zhou J. Li X, et al. J BUON. 2019 Nov-Dec;24(6):2539-2545. J BUON. 2019. PMID: 31983130 Free article.
PURPOSE: Small bowel adenocarcinoma (SBA) is an uncommon malignancy with poor prognosis and therefore difficult to study. The purpose of this study was to evaluate the characteristics, treatments and prognostic factors in patients with metastatic or locally unres …
PURPOSE: Small bowel adenocarcinoma (SBA) is an uncommon malignancy with poor prognosis and therefore difficult to study. The purpose …
Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options.
Davies JM, O'Neil B. Davies JM, et al. Expert Opin Investig Drugs. 2009 Jul;18(7):913-9. doi: 10.1517/13543780902939151. Expert Opin Investig Drugs. 2009. PMID: 19548850 Review.
BACKGROUND: Peritoneal carcinomatosis (PC) is a challenging consequence of certain malignancies, associated with a poor prognosis and limited treatment options. Generally, PC has been treated similarly to metastatic cancers of the primary tumor, but associate …
BACKGROUND: Peritoneal carcinomatosis (PC) is a challenging consequence of certain malignancies, associated with a poor prognosis …
Survival impact of occult liver metastasis and peritoneal dissemination compared with radiologically defined distant organ metastasis in pancreatic ductal adenocarcinoma.
Hashimoto D, Sakaguchi T, Satoi S, Yamamoto T, Yamaki S, Ishida M, Matsui Y, Shibata N, Boku S, Katsushima U, Ikeura T, Sekimoto M. Hashimoto D, et al. Pancreatology. 2023 Jan;23(1):73-81. doi: 10.1016/j.pan.2022.11.012. Epub 2022 Dec 1. Pancreatology. 2023. PMID: 36494309
OBJECTIVE: We aimed to clarify the prognosis of OM compared with RM and to establish a treatment strategy for PDAC patients with OM. ...CONCLUSION: The prognosis of PDAC with OM was relatively better than that with RM, but general and nutritional statuses, primar …
OBJECTIVE: We aimed to clarify the prognosis of OM compared with RM and to establish a treatment strategy for PDAC patients with OM. …
Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction.
Hiramoto S, Kikuchi A, Tetsuso H, Yoshioka A, Kohigashi Y, Maeda I. Hiramoto S, et al. Int J Clin Oncol. 2018 Dec;23(6):1090-1094. doi: 10.1007/s10147-018-1317-0. Epub 2018 Jul 17. Int J Clin Oncol. 2018. PMID: 30019177
BACKGROUND: Bleeding and obstruction are common localized symptoms in patients with unresectable gastric cancer. Although there are several reports about surgical and endoscopic therapies for gastric cancer, there are few regarding palliative radiation therapy. ...Adverse …
BACKGROUND: Bleeding and obstruction are common localized symptoms in patients with unresectable gastric cancer. Although there are s …
Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
Hompes D, Boot H, van Tinteren H, Verwaal V. Hompes D, et al. J Surg Oncol. 2011 Sep 1;104(3):269-73. doi: 10.1002/jso.21937. Epub 2011 Apr 4. J Surg Oncol. 2011. PMID: 21465492 Clinical Trial.
BACKGROUND AND OBJECTIVES: For unresectable peritoneal carcinomatosis (PC) median overall survival (OS) is 5-6 months. ...Primary tumors were right-sided in >50% and had been previously resected in >58%, 74.4% of PC occurred synchronously. ...
BACKGROUND AND OBJECTIVES: For unresectable peritoneal carcinomatosis (PC) median overall survival (OS) is 5-6 months. ...P …
Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
Chan DY, Syn NL, Yap R, Phua JN, Soh TI, Chee CE, Nga ME, Shabbir A, So JB, Yong WP. Chan DY, et al. J Gastrointest Surg. 2017 Mar;21(3):425-433. doi: 10.1007/s11605-016-3336-3. Epub 2016 Dec 15. J Gastrointest Surg. 2017. PMID: 27981493
Peritoneal metastasis is common in gastric cancer. It is difficult to treat and carries a poor prognosis. ...Patients with unresectable and/or recurrent gastric adenocarcinoma with peritoneal dissemination and/or positive peritoneal washing cyto …
Peritoneal metastasis is common in gastric cancer. It is difficult to treat and carries a poor prognosis. ...Patients with …
51 results